+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bioprocess Technology Market Analysis, By Product, By Application, By End User, and by Region - Global Forecast to 2029

  • PDF Icon

    Report

  • 139 Pages
  • September 2022
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5653900
The bioprocess technology market size is estimated to be USD 18,311.5 million in 2021 and is expected to witness a CAGR of 15.77% during the forecast period 2022-2029. The widespread use of bioprocess technology, pharmaceuticals, agriculture, and biotechnology are some of the factors contributing to the market growth. Additionally, rising expenditures on R&D in the biotechnology sector, spike in vaccine demand, ongoing technological advancements, rising number of new drug production and launches, and rising incidence of cancer and HIV are other factors contributing the market growth. However, high price of the instruments is expected to hinder the growth.

By Product

Based on product, the market is categorized into cell counting, cell culture, biologics safety testing, flow cytometry, tangential flow filtration, cell line development, and cell expansion. In 2021, the biologics safety testing accounted for the highest revenue share due to the growing government support for the biotechnology and pharmaceutical industries.

By Application

On the basis of application, the market is categorized into biosimilars, recombinant proteins, antibiotics, and others. In the global market, the recombinant proteins segment accounted for the largest revenue share in 2021 owing to the increase in demand for recombinant proteins in medicinal applications.

By End User

Based on end user, the market is segmented into contract research organization, contract manufacturing organization, biopharmaceutical companies, academic research institutes, and food & feed industry. In 2021, the biopharmaceutical companies segment accounted for the largest revenue share owing to rising need for improved bioprocess technology for the creation of cutting-edge pharmaceuticals and vaccines.

Regional Markets In 2021, North America region accounted for the highest revenue in the bioprocess technology market and is expected to maintain its dominance during the forecast period. This is attributed to the increasing demand for high-quality biologics, the widespread presence of numerous domestic and international market participants, and the rising expenditure in research and development activities by these market players.

Competitor Insights

Some of the key players operating in the bioprocess technology market are Lonza Group AG (Switzerland), Becton, Dickinson and Company (U.S), Thermo Fisher Scientific, Inc. (U.S), Merck Millipore (Germany), Sartorius Stedim Biotech S.A (France), GE Healthcare (U.S), Corning, Inc. (U.S), Bio-Rad Laboratories (U.S), Danaher Corporation (U.S), and Charles River Laboratories (U.S).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product, application, and end user from 2021 to 2029.

Segmentation: Bioprocess Technology Market Report 2021-2029

Product (Revenue, USD Million)

  • Cell Counting
  • Cell Culture
  • Biologics Safety Testing
  • Flow Cytometry
  • Tangential Flow Filtration
  • Cell Line Development
  • Cell Expansion

Application (Revenue, USD Million)

  • Biosimilars
  • Recombinant Proteins
  • Antibiotics
  • Others

End user (Revenue, USD Million)

  • Contract Research Organization
  • Contract Manufacturing Organization
  • Biopharmaceutical Companies
  • Academic Research Institutes
  • Food & Feed Industry

By Region (Revenue, USD Million)

North America

  • U.S
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
1.4.1. Research Models
1.4.1.1. Bottom-up Approach
1.4.1.2. Top-down Approach
1.4.1.3. Data Triangulation
1.4.2. Data Procurement
1.4.2.1. Internal Database
1.4.2.2. Secondary Research
1.4.2.3. Purchased Database
1.4.2.4. Primary Research
1.4.3. Data Analysis
1.4.3.1. Data Validation
1.4.3.2. Market Size Estimation
1.4.3.3. Market Forecast Model
1.4.4. Quality Assessment
2. Introduction: Bioprocess Technology
3. Executive Summary
3.1. Global Market Scenario
3.2. Segment Market Scenario
3.3. Geographic Market Scenario
3.4. COVID-19 Impact
3.5. Competitive Landscape
4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.1.5. Driver 5
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.2.4. Restraint 4
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.3.4. Opportunity 4
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.4.4. Trend 4
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3
4.5.4. Challenge 4
5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. Value Chain Analysis
5.4. SWOT Analysis
5.5. Benchmark
6. COVID-19 Impact Analysis: Bioprocess Technology Market
6.1. COVID-19: Overview
6.2. COVID-19 Impact on the Global Market
6.3. COVID-19 Impact on the Regional Markets
7. Market Analysis by Product
7.1. Cell Counting
7.1.1. Cell Counting Market Forecast, 2021-2029 (USD Million)
7.2. Cell Culture
7.2.1. Cell Culture Market Forecast, 2021-2029 (USD Million)
7.3. Biologics Safety Testing
7.3.1. Biologics Safety Testing Market Forecast, 2021-2029 (USD Million)
7.4. Flow Cytometry
7.4.1. Flow Cytometry Market Forecast, 2021-2029 (USD Million)
7.5. Tangential Flow Filtration
7.5.1. Tangential Flow Filtration Market Forecast, 2021-2029 (USD Million)
7.6. Cell Line Development
7.6.1. Cell Line Development Market Forecast, 2021-2029 (USD Million)
7.7. Cell Expansion
7.7.1. Cell Expansion Market Forecast, 2021-2029 (USD Million)
8. Market Analysis by Application
8.1. Biosimilars
8.1.1. Biosimilars Market Forecast, 2021-2029 (USD Million)
8.2. Recombinant Proteins
8.2.1. Recombinant Proteins Market Forecast, 2021-2029 (USD Million)
8.3. Antibiotics
8.3.1. Antibiotics Market Forecast, 2021-2029 (USD Million)
8.4. Others
8.4.1. Others Market Forecast, 2021-2029 (USD Million)
9. Market Analysis by End User
9.1. Contract Research Organization
9.1.1. Contract Research Organization Market Forecast, 2021-2029 (USD Million)
9.2. Contract Manufacturing Organization
9.2.1. Contract Manufacturing Organization Market Forecast, 2021-2029 (USD Million)
9.3. Biopharmaceutical Companies
9.3.1. Biopharmaceutical Companies Market Forecast, 2021-2029 (USD Million)
9.4. Academic Research Institutes
9.4.1. Academic Research Institutes Market Forecast, 2021-2029 (USD Million)
9.5. Food & Feed Industry
9.5.1. Food & Feed Industry Market Forecast, 2021-2029 (USD Million)
10. Regional Market Analysis
10.1. Regional Market Trends
10.2. Regional Market: Comparative Analysis
11. North America Bioprocess Technology Market
11.1. North America Bioprocess Technology Market
11.1.1. North America Market Size and Forecast, 2021-2029 (USD Million)
11.1.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
11.1.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
11.1.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
11.2. U. S. Bioprocess Technology Market
11.2.1. U. S. Market Size and Forecast, 2021-2029 (USD Million)
11.2.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
11.2.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
11.2.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
11.3. Canada Bioprocess Technology Market
11.3.1. Canada Market Size and Forecast, 2021-2029 (USD Million)
11.3.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
11.3.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
11.3.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
12. Europe Bioprocess Technology Market
12.1. Europe Bioprocess Technology Market
12.1.1. Europe Market Size and Forecast, 2021-2029 (USD Million)
12.1.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.1.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
12.1.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
12.2. Germany Bioprocess Technology Market
12.2.1. Germany Market Size and Forecast, 2021-2029 (USD Million)
12.2.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.2.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
12.2.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
12.3. UK Bioprocess Technology Market
12.3.1. UK Market Size and Forecast, 2021-2029 (USD Million)
12.3.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.3.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
12.3.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
12.4. France Bioprocess Technology Market
12.4.1. France Market Size and Forecast, 2021-2029 (USD Million)
12.4.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.4.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
12.4.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
12.5. Spain Bioprocess Technology Market
12.5.1. Spain Market Size and Forecast, 2021-2029 (USD Million)
12.5.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.5.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
12.5.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
12.6. Italy Bioprocess Technology Market
12.6.1. Italy Market Size and Forecast, 2021-2029 (USD Million)
12.6.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.6.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
12.6.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
12.7. Rest of Europe Bioprocess Technology Market
12.7.1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
12.7.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.7.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
12.7.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
13. Asia Pacific Bioprocess Technology Market
13.1. Asia Pacific Bioprocess Technology Market
13.1.1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
13.1.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.1.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
13.1.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
13.2. Japan Bioprocess Technology Market
13.2.1. Japan Market Size and Forecast, 2021-2029 (USD Million)
13.2.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.2.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
13.2.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
13.3. China Bioprocess Technology Market
13.3.1. China Market Size and Forecast, 2021-2029 (USD Million)
13.3.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.3.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
13.3.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
13.4. India Bioprocess Technology Market
13.4.1. India Market Size and Forecast, 2021-2029 (USD Million)
13.4.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.4.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
13.4.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
13.5. South Korea Bioprocess Technology Market
13.5.1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
13.5.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.5.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
13.5.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
13.6. Australia Bioprocess Technology Market
13.6.1. Australia Market Size and Forecast, 2021-2029 (USD Million)
13.6.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.6.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
13.6.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
13.7. Rest of Asia Pacific Bioprocess Technology Market
13.7.1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
13.7.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.7.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
13.7.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
14. Latin America Bioprocess Technology Market
14.1. Latin America Bioprocess Technology Market
14.1.1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
14.1.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
14.1.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
14.1.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
14.2. Brazil Bioprocess Technology Market
14.2.1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
14.2.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
14.2.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
14.2.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
14.3. Mexico Bioprocess Technology Market
14.3.1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
14.3.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
14.3.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
14.3.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
14.4. Argentina Bioprocess Technology Market
14.4.1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
14.4.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
14.4.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
14.4.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
14.5. Rest of Latin America Bioprocess Technology Market
14.5.1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
14.5.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
14.5.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
14.5.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
15. MEA Bioprocess Technology Market
15.1. MEA Bioprocess Technology Market
15.1.1. MEA Market Size and Forecast, 2021-2029 (USD Million)
15.1.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
15.1.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
15.1.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
15.2. GCC Bioprocess Technology Market
15.2.1. GCC Market Size and Forecast, 2021-2029 (USD Million)
15.2.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
15.2.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
15.2.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
15.3. South Africa Bioprocess Technology Market
15.3.1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
15.3.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
15.3.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
15.3.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
15.4. Rest of MEA Bioprocess Technology Market
15.4.1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
15.4.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
15.4.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
15.4.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
16. Competitor Analysis
16.1. Market Share Analysis, 2021 & 2029
16.2. Competitive Mapping
16.3. Key Players Market Place Analysis
16.4. Major Recent Developments
17. Company Profiles
17.1. Lonza Group AG (Switzerland)
17.1.1. Company Snapshot
17.1.2. Company Overview
17.1.3. Financials
17.1.4. Application Benchmarking
17.1.5. Recent Developments
17.2. Becton, Dickinson and Company (U. S.)
17.2.1. Company Snapshot
17.2.2. Company Overview
17.2.3. Financials
17.2.4. Application Benchmarking
17.2.5. Recent Developments
17.3. Thermo Fisher Scientific, Inc. (U. S.)
17.3.1. Company Snapshot
17.3.2. Company Overview
17.3.3. Financials
17.3.4. Application Benchmarking
17.3.5. Recent Developments
17.4. Merck Millipore (Germany)
17.4.1. Company Snapshot
17.4.2. Company Overview
17.4.3. Financials
17.4.4. Application Benchmarking
17.4.5. Recent Developments
17.5. Sartorius Stedim Biotech S. A (France)
17.5.1. Company Snapshot
17.5.2. Company Overview
17.5.3. Financials
17.5.4. Application Benchmarking
17.5.5. Recent Developments
17.6. GE Healthcare (U. S.)
17.6.1. Company Snapshot
17.6.2. Company Overview
17.6.3. Financials
17.6.4. Application Benchmarking
17.6.5. Recent Developments
17.7. Corning, Inc. (U. S.)
17.7.1. Company Snapshot
17.7.2. Company Overview
17.7.3. Financials
17.7.4. Application Benchmarking
17.7.5. Recent Developments
17.8. Bio-Rad Laboratories (U. S.)
17.8.1. Company Snapshot
17.8.2. Company Overview
17.8.3. Financials
17.8.4. Application Benchmarking
17.8.5. Recent Developments
17.9. Danaher Corporation (U. S.)
17.9.1. Company Snapshot
17.9.2. Company Overview
17.9.3. Financials
17.9.4. Application Benchmarking
17.9.5. Recent Developments
17.10. Charles River Laboratories (U. S.)
17.10.1. Company Snapshot
17.10.2. Company Overview
17.10.3. Financials
17.10.4. Application Benchmarking
17.10.5. Recent Developments
17.11. Company 11
17.11.1. Company Snapshot
17.11.2. Company Overview
17.11.3. Financials
17.11.4. Product Benchmarking
17.11.5. Recent Developments
17.12. Company 12
17.12.1. Company Snapshot
17.12.2. Company Overview
17.12.3. Financials
17.12.4. Product Benchmarking
17.12.5. Recent Developments
17.13. Company 13
17.13.1. Company Snapshot
17.13.2. Company Overview
17.13.3. Financials
17.13.4. Product Benchmarking
17.13.5. Recent Developments
17.14. Company 14
17.14.1. Company Snapshot
17.14.2. Company Overview
17.14.3. Financials
17.14.4. Product Benchmarking
17.14.5. Recent Developments
17.15. Company 15
17.15.1. Company Snapshot
17.15.2. Company Overview
17.15.3. Financials
17.15.4. Product Benchmarking
17.15.5. Recent Developments
17.16. Others Prominent Players
18. Conclusion & Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Lonza Group AG (Switzerland)
  • Becton
  • Dickinson and Company (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Merck Millipore (Germany)
  • Sartorius Stedim Biotech S.A (France)
  • GE Healthcare (U.S.)
  • Corning Inc. (U.S.)
  • Bio-Rad Laboratories (U.S.)
  • Danaher Corporation (U.S.)
  • Charles River Laboratories (U.S.).